Jury Looking Pensive


A federal jury in New Orleans recently sided with drugmakers Bayer AG and Johnson & Johnson in the first bellwether trial from plaintiffs alleging they were harmed by the blood-thinning drug Xarelto.

Joseph Boudreaux, 75, of Louisiana blamed the drugmakers for life-threatening bleeding after taking the drug.

He is the first in a series of four Xarelto bellwether cases (test trials) set to take place this summer in a consolidated legal action called a multidistrict litigation that involves nearly 20,000 plaintiffs.

The verdicts in these trials will assist other plaintiffs and the drug companies assess potential outcomes and values of similar claims in pending litigation.

Visit Original Source